Production & Sales

J&J announces agreement with US govt for 100 million doses of investigational Covid-19 vaccine

Johnson & Johnson (J&J) announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen's SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval or Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).

Sanofi, GSK to supply US govt with 100 million doses of Covid-19 vaccine

Sanofi and GSK today announce a collaborative effort with the U.S. government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine.

DFC grants $765m loan to Kodak to establish new pharma business unit

The US International Development Finance Corporation (DFC) has agreed to provide a $765m loan to Eastman Kodak Company to help create a new pharmaceutical business unit.

Pfizer, BioNTech sign $1.95bn deal with US govt for supply of Covid-19 vaccine candidate

The US government has placed an order worth $1.95bn with Pfizer and BioNTech to procure 100 million doses of their BNT162 vaccine candidate for Covid-19.

Pfizer, BioNTech announce agreement with UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2

Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million doses of their BNT162 mRNA-based vaccine candidate against SARS-CoV-2, currently in development, subject to clinical success and regulatory approval.

Novartis to offer not-for-profit medicines to treat Covid-19 patients

Swiss pharmaceutical firm Novartis has announced that its Sandoz division will provide a portfolio of 15 not-for-profit generic and over-the-counter (OTC) medicines to developing countries to treat the patients with Covid-19 symptoms.

Oxygen Sensor InPro 6860iHD

Reliable Oxygen Measurements Continuous dissolved oxygen (DO) measurement is critical during fermentation and cell culture.

KKR to acquire controlling stake in J.B. Chemicals & Pharmaceuticals

Global investment firm KKR today announced that it has entered into a definitive agreement to purchase a controlling stake in J.B. Chemicals & Pharmaceuticals Ltd. (NSE: JBCHEPHARM) (“J.B. Chemicals” or “the Company” or “JBCPL”), one of the leading Indian pharmaceutical companies specializing in branded formulations.

Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m

US private equity firm Carlyle Group has agreed to acquire a stake of 20% stake in Piramal Pharma, the pharmaceutical business of Indian conglomerate Piramal Enterprises, in a deal worth up to $490m.